Avera Pharmaceuticals, Inc.
Industry
- Biotechnology
- Pharmaceuticals
- Specialty Pharmaceuticals
Latest on Avera Pharmaceuticals, Inc.
Trials of cardiovascular devices, including peripheral interventions, are highlighted in this month's edition of Starts & Stops, Medtech Insight' s regular feature on medtech clinical trials that hav
Avanir Pharmaceuticals has appointed Dr Joao Siffert to the newly created role of senior vice-president of research and development. Dr Siffert previously served as vice-president and chief medical of
Big Pharma is eager to license the drugs or buy their developers, and the market is huge. So why aren’t more venture capitalists investing in Alzheimer’s drug discovery? By Christopher Morrison The co
The business problem with ideas is that they're often unprotectable. That's why drug companies have always preferred to create things —or, in intellectual property parlance, compositions of matter. P